CFO Amy O’Keefe Buys Nearly 67,000 Shares at Sleep Number, Betting on Turnaround Success Amid Low Prices

Insider Buying at Sleep Number Signals Confidence Amid a Challenging Turnaround

On March 16, 2026, EVP and Chief Financial Officer Amy O’Keefe purchased 66,965 shares of Sleep Number Corp. at $0.00 per share, a transaction that added 136,707 shares to her holdings in restricted stock units that will vest over time. The purchase occurred just days after the company’s March 12 filing, which outlined a turnaround strategy aimed at product simplification, cost reduction, and a refreshed credit agreement. O’Keefe’s action comes at a time when the stock is trading near its 52‑week low of $3.44, and the company’s price‑earnings ratio is negative, signaling a distressed valuation that may leave room for upside if the restructuring succeeds.

The timing of the buy is noteworthy. O’Keefe’s most recent historic transaction was on December 15, 2025, when she bought 69,742 shares. The pattern of incremental purchases—particularly the shift from a flat purchase price of $0.00 to a current market price of $3.22—suggests she views the company’s share price as undervalued relative to its long‑term prospects. Her recent purchase of 66,965 shares is slightly smaller than the December batch but larger than the 2024‑style restricted‑unit grant, indicating a balance between conviction and risk management. For investors, this insider activity can be interpreted as a vote of confidence: executives who own the company’s future are willing to commit capital at a depressed price.

What It Means for Investors

Insider buying is generally a bullish signal, especially when it occurs in a company that is aggressively restructuring. Sleep Number’s current plan focuses on streamlining its product line, tightening margins, and improving cash flow. The CFO’s purchase reinforces the narrative that management believes the turnaround plan will materialize. For the broader investor base, the transaction also provides a subtle hedge against the stock’s high volatility: insiders are less likely to sell unless they see a fundamental shift in company performance. Moreover, the restricted stock units that will vest over time create a long‑term incentive for O’Keefe to support the company’s strategic objectives, aligning her interests with those of shareholders.

That said, the company is still in the early stages of its restructuring, and the market’s negative sentiment—evidenced by a 39.25% weekly decline and a 69.01% monthly decline—remains a risk factor. Investors should monitor key metrics such as free‑cash‑flow generation, margin improvement, and the execution of the credit agreement outlined in the latest filing. If these indicators improve, O’Keefe’s buy could presage a broader buying wave from other insiders and institutional investors.

Profile of Amy O’Keefe: A Steady Investor

O’Keefe’s insider transaction history shows a consistent, cautious approach. Her December 2025 purchase of 69,742 shares at zero cost—likely a vesting of previously granted units—indicates she has a long‑term view and prefers to acquire shares when they are most cost‑effective. The March 2026 transaction, while made at the current market price, is still executed at a price substantially below the stock’s 52‑week high of $13.94, suggesting she remains optimistic about upside potential. Her holdings have increased from 69,742 to 136,707 shares, a 96% expansion over a year, reflecting both new purchases and vesting of restricted units.

Unlike some insiders who engage in frequent trading, O’Keefe’s activity has been measured. She does not appear to sell shares, maintaining a “buy” stance throughout her history. This long‑term commitment is reinforced by the nature of her role: as CFO, she is intimately involved in the company’s financial strategy and risk management, making her particularly attuned to the health of the balance sheet and the success of the turnaround plan.

Bottom Line for the Market

Amy O’Keefe’s purchase of nearly 67,000 shares at a time when Sleep Number is trading near its 52‑week low is a signal that insiders are betting on the company’s restructuring. For investors, it provides a subtle endorsement of the CEO’s turnaround plan and a potential catalyst for broader market confidence. While the stock remains volatile and the company’s negative earnings ratio raises concerns, the CFO’s commitment—backed by a substantial restricted‑unit grant that will vest over time—suggests that management sees a credible path to profitability. Keeping an eye on the company’s cash flow and margin metrics will be key to assessing whether this insider confidence translates into shareholder gains.